Purpose and goal
With a new medical technology tool (BiopsyTool, BT) replace surgical sentinel node biopsy with a less invasive, ultrasound- and gamma probe-guided fine-needle biopsy. BT is expected to improve diagnostic accuracy, enable personalised treatment, streamline care and free resources. The project will develop a process to integrate BT into clinical routine and evaluate benefit, safety and acceptance. A model will also be developed for implementation and spread within healthcare.
Expected effects and result
Expected results is a new process where BiopsyTool replaces surgical sentinel node biopsy. Effects include improved diagnostic accuracy, reduced complications, shorter treatment times and more efficient resource use. The project is also expected to enable more personalized treatment, especially in immunotherapy, as well as contribute to reduced healthcare costs and strengthened Swedish medical technology innovation.
Planned approach and implementation
The project is carried out in four stages:
1. mapping of the current process,
2. development of a new process with BiopsyTool,
3. gap analysis and action plan for implementation, and
4. testing in a clinical project.
The work is carried out in close collaboration with healthcare professionals, technology developers and patients. Evaluation is carried out continuously of effectiveness, safety, costs and user acceptance, with training efforts and feedback in each phase.
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
